AAAAAA
Results: 1-25/36
Authors:
Llevadot, J
Giugliano, RP
Antman, EM
Wilcox, RG
Gurfinkel, EP
Henry, T
McCabe, CH
Charlesworth, A
Thompson, S
Nicolau, JC
Tebbe, U
Sadowski, Z
Braunwald, E
Citation: J. Llevadot et al., Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction, EUR HEART J, 22(22), 2001, pp. 2104-2115
Authors:
Giugliano, RP
Llevadot, J
Wilcox, RG
Gurfinkel, EP
McCabe, CH
Charlesworth, A
Thompson, SL
Antman, EM
Braunwald, E
Citation: Rp. Giugliano et al., Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis - Results from InTIME-II, EUR HEART J, 22(18), 2001, pp. 1702-1715
Authors:
Morrow, DA
Antman, EM
Giugliano, RP
Cairns, R
Charlesworth, A
Murphy, SA
de Lemos, JA
McCabe, CH
Braunwald, E
Citation: Da. Morrow et al., A simple risk index for rapid initial triage of patients with ST-elevationmyocardial infarction: an InTIME II substudy, LANCET, 358(9293), 2001, pp. 1571-1575
Authors:
Morrow, DA
Antman, EM
Parsons, L
de Lemos, JA
Cannon, CP
Giugliano, RP
McCabe, CH
Barron, HV
Braunwald, E
Citation: Da. Morrow et al., Application of the TIMI risk score for ST-Elevation MI in the National Registry of Myocardial Infarction 3, J AM MED A, 286(11), 2001, pp. 1356-1359
Authors:
de Lemos, JA
Morrow, DA
Bentley, JH
Omland, T
Sabatine, MS
McCabe, CH
Hall, C
Cannon, CP
Braunwald, E
Citation: Ja. De Lemos et al., The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes, N ENG J MED, 345(14), 2001, pp. 1014-1021
Authors:
Morrow, DA
Antman, EM
de Lemos, JA
Giugliano, RP
McCabe, CH
Braunwald, E
Murphy, SA
Charlesworth, A
Cairns, R
Citation: Da. Morrow et al., Death rates versus deaths - Response, CIRCULATION, 104(2), 2001, pp. E8-E8
Authors:
Gibson, CM
de Lemos, JA
Murphy, SA
Marble, SJ
McCabe, CH
Cannon, CP
Antman, EM
Braunwald, E
Citation: Cm. Gibson et al., Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction - A TIMI 14 substudy, CIRCULATION, 103(21), 2001, pp. 2550-2554
Authors:
de Lemos, JA
Morrow, DA
Gibson, CM
Murphy, SA
Rifai, N
Tanasijevic, M
Giugliano, RP
Schuhwerk, KC
McCabe, CH
Cannon, CP
Antman, EM
Braunwald, E
Citation: Ja. De Lemos et al., Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy, AM J CARD, 88(4), 2001, pp. 353-358
Authors:
Holper, EM
Antman, EM
McCabe, CH
Premmereur, J
Gurfinkel, E
Bernink, PJLM
Turpie, AG
de Luna, AB
Lablanche, JM
Fox, KM
Salein, D
Radley, DR
Braunwald, E
Citation: Em. Holper et al., A simple, readily available method for risk stratification of patients with uns unstable angina and non-ST elevation myocardial infarction, AM J CARD, 87(8), 2001, pp. 1008
Authors:
Cannon, CP
McCabe, CH
Wilcox, RG
Bentley, JH
Braunwald, E
Citation: Cp. Cannon et al., Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris, AM J CARD, 87(5), 2001, pp. 636-639
Authors:
Gibson, CM
Murphy, SA
Marble, SJ
McCabe, CH
Antman, EM
Cannon, CP
Braunwald, E
Citation: Cm. Gibson et al., Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytictrials?, AM J CARD, 87(4), 2001, pp. 450
Authors:
Giugliano, RP
McCabe, CH
Antman, EM
Cannon, CP
Van de Werf, F
Wilcox, RG
Braunwald, E
Citation: Rp. Giugliano et al., Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage, AM HEART J, 141(5), 2001, pp. 742-750
Authors:
Santopinto, J
Gurfinkel, EP
Torres, V
Marcos, E
Bozovich, GE
Mautner, B
McCabe, CH
Antman, EM
Citation: J. Santopinto et al., Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin, AM HEART J, 141(4), 2001, pp. 566-572
Authors:
Morrow, DA
Antman, EM
Tanasijevic, M
Rifai, N
de Lemos, JA
McCabe, CH
Cannon, CP
Braunwald, E
Citation: Da. Morrow et al., Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: A TIMI-11B substudy, J AM COL C, 36(6), 2000, pp. 1812-1817
Authors:
Morrow, DA
Rifai, N
Antman, EM
Weiner, DL
McCabe, CH
Cannon, CP
Braunwald, E
Citation: Da. Morrow et al., Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy, J AM COL C, 35(2), 2000, pp. 358-362
Authors:
Antman, EM
Gibson, CM
de Lemos, JA
Giugliano, RP
McCabe, CH
Coussement, P
Menown, I
Nienaber, CA
Rehders, TC
Frey, NJ
Van der Wieken, R
Andresen, D
Scherer, J
Anderson, K
Van de Werf, F
Braunwald, E
Citation: Em. Antman et al., Combination reperfusion therapy with abciximab and reduced dose reteplase:results from TIMI 14, EUR HEART J, 21(23), 2000, pp. 1944-1953
Authors:
Antman, EM
Cohen, M
Bernink, PJLM
McCabe, CH
Horacek, T
Papuchis, G
Mautner, B
Corbalan, R
Radley, D
Braunwald, E
Citation: Em. Antman et al., The TIMI risk score for unstable angina/non-ST elevation MI - A method forprognostication and therapeutic decision making, J AM MED A, 284(7), 2000, pp. 835-842
Authors:
de Lemos, JA
Antman, EM
Morrow, DA
Llevadot, J
Giugliano, RP
Coulter, SA
Schuhwerk, KC
Arslanian, S
McCabe, CH
Gibson, CM
Rifai, N
Citation: Ja. De Lemos et al., Heart-Type Fatty Acid Binding Protein as a marker of reperfusion after thrombolytic therapy, CLIN CHIM A, 298(1-2), 2000, pp. 85-97
Authors:
Gibson, CM
Murphy, SA
Rizzo, MJ
Ryan, KA
Marble, SJ
McCabe, CH
Cannon, CP
Van de Werf, F
Braunwald, E
Citation: Cm. Gibson et al., Is the corrected TIMI frame count an independent predictor of adverse outcome? Response, CIRCULATION, 102(2), 2000, pp. E19-E19
Authors:
Cannon, CP
McCabe, CH
Wilcox, RG
Langer, A
Caspi, A
Berink, P
Lopez-Sendon, J
Toman, J
Charlesworth, A
Anders, RJ
Alexander, JC
Skene, A
Braunwald, E
Citation: Cp. Cannon et al., Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial, CIRCULATION, 102(2), 2000, pp. 149-156
Authors:
Morrow, DA
Antman, EM
Charlesworth, A
Cairns, R
Murphy, SA
de Lemos, JA
Giugliano, RP
McCabe, CH
Braunwald, E
Citation: Da. Morrow et al., TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation - An intravenous nPA for treatment of infarcting myocardium early II trial substudy, CIRCULATION, 102(17), 2000, pp. 2031-2037
Authors:
de Lemos, JA
Antman, EM
Gibson, CM
McCabe, CH
Giugliano, RP
Murphy, SA
Coulter, SA
Anderson, K
Scherer, J
Frey, MJ
Van der Wieken, R
Van de Werf, F
Braunwald, E
Citation: Ja. De Lemos et al., Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction - Observations from the TIMI 14 trial, CIRCULATION, 101(3), 2000, pp. 239-243
Authors:
Gibson, CM
Cannon, CP
Murphy, SA
Ryan, KA
Mesley, R
Marble, SJ
McCabe, CH
Van de Werf, F
Braunwald, E
Citation: Cm. Gibson et al., Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs, CIRCULATION, 101(2), 2000, pp. 125-130
Authors:
de Lemos, JA
Antman, EM
Giugliano, RP
Morrow, DA
McCabe, CH
Cutler, SS
Charlesworth, A
Schroder, R
Braunwald, E
Citation: Ja. De Lemos et al., Comparison of a 60-versus 90-minute determination of ST-segment resolutionafter thrombolytic therapy for acute myocardial infarction, AM J CARD, 86(11), 2000, pp. 1235
Authors:
de Lemos, JA
Antman, EM
Giugliano, RP
McCabe, CH
Murphy, SA
Van de Werf, F
Gibson, CM
Braunwald, E
Citation: Ja. De Lemos et al., ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy, AM J CARD, 85(3), 2000, pp. 299-304